
    
      The study will compare the effect of IV infusion or IV bolus to IM oxytocin administration
      with respect to mean blood loss and the proportion of women who experience blood loss greater
      than or equal to 500 ml, women who experience blood loss greater than or equal to 350 ml,
      side effects, adverse events and change in hemoglobin pre- to post-delivery.
    
  